-
Redox therapy is an
experimental therapy that aims to
effect an
outcome by
modifying the
levels of pro-oxidant and
antioxidant agents in cells. The term...
-
Later in July of the same year, the
company announced it
would acquire RedoxTherapies for $10 million. This
acquisition provides Juno with an
exclusive license...
-
Biomedicines (Acq 2018) Juno
Therapeutics (Acq 2018)
AbVitro (Acq 2016)
RedoxTherapies (Acq 2016) In
March 2016, Bob Hugin, the company's long
serving CEO...
-
Biomedicines (Acq 2018) Juno
Therapeutics (Acq 2018)
AbVitro (Acq 2016)
RedoxTherapies (Acq 2016)
Forbius (Acq 2020)
MyoKardia (Acq 2020)
Turning Point Therapeutics...
-
Immunoliposome therapy is a
targeted drug
delivery method that
involves the use of
liposomes (artificial
lipid bilayer vesicles)
coupled with monoclonal...
-
redox-active ions or compounds,
including most
transition metals and
their compounds (e.g.
manganese dioxide (MnO2), silver, and platinum). The
redox...
- (October 2017). "Ferroptosis: A
Regulated Cell
Death Nexus Linking Metabolism,
Redox Biology, and Disease". Cell. 171 (2): 273–285. doi:10.1016/j.cell.2017.09...
- in
three redox states,
fully oxidized (ubiquinone),
partially reduced (semiquinone or ubisemiquinone), and
fully reduced (ubiquinol). The
redox functions...
-
Experimental cancer treatments are
mainstream medical therapies intended to
treat cancer by
improving on,
supplementing or
replacing conventional methods...
-
Antimicrobial photodynamic therapy (aPDT), also
referred to as
photodynamic inactivation (PDI),
photodisinfection (PD), or
photodynamic antimicrobial...
